For: | Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol 2009; 15(6): 641-646 [PMID: 19222088 DOI: 10.3748/wjg.15.641] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/641.htm |
Number | Citing Articles |
1 |
A. Slack, A. Yeoman, J. Wendon. Intensive Care Medicine. 2010; : 349 doi: 10.1007/978-1-4419-5562-3_33
|
2 |
Marco Lombardi. Making the Point on Hepatitis B and C in Dialysis: Role of Patients' Isolation. Giornale di Tecniche Nefrologiche e Dialitiche 2014; 26(4): 321 doi: 10.5301/GTND.2014.12396
|
3 |
Nahid Ramezan Ghorbani, Shirin Djalalinia, Mitra Modirian, Zahra Esmaeili Abdar, Morteza Mansourian, Armita Mahdavi Gorabi, Hamid Asayesh, Hossein Ansari, Mehrdad Kazemzadeh Atoofi, Ramin Tajbakhsh, Mehdi Noroozi, Saeid Safiri, Mostafa Qorbani. Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis. Journal of Research in Medical Sciences 2017; 22(1) doi: 10.4103/jrms.JRMS_223_17
|
4 |
S Datta, N Goel, C Wattal. Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients. Indian Journal of Medical Microbiology 2015; 33: S106 doi: 10.4103/0255-0857.148832
|
5 |
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
|
6 |
Seyed-Moayed Alavian, Seyed-Vahid Tabatabaei, Nastaran Mahboobi. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. Journal of Public Health 2011; 19(2): 191 doi: 10.1007/s10389-010-0366-2
|
7 |
Ignatius Y. S. Tang, Natasha Walzer, Nidhi Aggarwal, Ivo Tzvetanov, Scott Cotler, Enrico Benedetti. Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection. International Journal of Nephrology 2011; 2011: 1 doi: 10.4061/2011/245823
|
8 |
Meryem Güvenir, Emrah Guler, Deren Oygar, Ahmet Behlul, Kaya Suer. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84699
|
9 |
A. Slack, A. Yeoman, J. Wendon. Yearbook of Intensive Care and Emergency Medicine 2010. Yearbook of Intensive Care and Emergency Medicine 2010; 2010: 349 doi: 10.1007/978-3-642-10286-8_33
|
10 |
Hao-Hsi Kao, Kuo-Su Chen, Chih-Lang Lin, Jia-Jang Chang, Chien-Hung Lee. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis Patients. Nephron 2015; 130(2): 127 doi: 10.1159/000430988
|
11 |
Yue-Cheng Yu, Yue Wang, Chang-Lun He, Mao-Rong Wang, Yu-Ming Wang. Management of hepatitis C virus infection in hemodialysis patients. World Journal of Hepatology 2014; 6(6): 419-425 doi: 10.4254/wjh.v6.i6.419
|
12 |
Rising burden of Hepatitis C Virus in hemodialysis patients. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-438
|
13 |
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Ala I. Sharara. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients. Current Hepatitis Reports 2012; 11(4): 256 doi: 10.1007/s11901-012-0147-1
|
14 |
Marzieh Jamalidoust, Maryam Eskandari, Mazyar Ziyaeyan. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran. Jundishapur Journal of Microbiology 2021; 14(11) doi: 10.5812/jjm.118591
|
15 |
Dimie Aruna, Abubakar Adereti, Easley A. Munir. Prevalence of hepatitis C virus infection among hemodialysis patients: cohort study. American Journal of BioMedicine 2023; 11(1): 36 doi: 10.18081/2333-5106/2023.11/36
|
16 |
Mary Anne Bobinski. Health Care–Associated Hepatitis B and C Viruses: Legal Aspects. Clinics in Liver Disease 2010; 14(1): 105 doi: 10.1016/j.cld.2009.11.002
|
17 |
Seyyed Moayed Alavian. Seronegative anti‐hepatitis C virus antibody in hemodialysis patients. Hemodialysis International 2013; 17(2): 328 doi: 10.1111/j.1542-4758.2012.00738.x
|
18 |
Sohail Akhtar, Jamal Abdul Nasir, Muhammad Usman, Aqsa Sarwar, Rizwana Majeed, Baki Billah, Ming-Lung Yu. The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. PLOS ONE 2020; 15(5): e0232931 doi: 10.1371/journal.pone.0232931
|
19 |
Seyed Moayed Alavian. An Unbelievable Fact on “Dialysis Centers Without Hepatitis C Infection”. Nephro-Urology Monthly 2014; 6(2) doi: 10.5812/numonthly.17998
|
20 |
Soheil Ashkani-Esfahani, Seyed Moayed Alavian, Mohammad Salehi-Marzijarani. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World Journal of Gastroenterology 2017; 23(1): 151-166 doi: 10.3748/wjg.v23.i1.151
|
21 |
Seyed Moayed Alavian. Occult Hepatitis B and Hemodialysis Patients Need Increased Precautions With the Interpretation of Results. Therapeutic Apheresis and Dialysis 2010; 14(6): 609 doi: 10.1111/j.1744-9987.2010.00878.x
|